Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report
Cancer Feb 12, 2020
Farrukh N, Hageman L, Chen Y, et al. - Researchers examined the prevalence and predictors of pain after blood or marrow transplantation [BMT] (allogeneic or autologous) and its correlation with physical performance impairments and frailty utilizing the Bone Marrow Transplant Survivor Study. The cohort comprised 736 individuals with hematologic malignancies who had BMT at an age ≥ 60 years at 1 of 3 transplant centers between 1974 and 2014 and survived ≥ 2 years after BMT. One hundred eighty-three unaffected siblings also engaged. According to findings, almost 40% of older BMT survivors who were followed for a median of 5 years after BMT reported pain, and BMT survivors had 2.6-fold higher chances of reporting severe, nonminor or life-interfering pain in comparison with siblings.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries